Omega Healthcare InvestorsBSP:O2HI34 -0.03%49 3-Year EPS without NRI Growth Rate is 38.90% as of Mar. 2026, which is 369% above its 10-year median of 8.30. GuruFocus rates BSP:O2HI34 with a GF Score™ of 49/100 and a GF Value™ of R$60.64 (Modestly Overvalued). The stock has 6 warning signs investors should review. Among 682 REITs companies, Omega Healthcare Investors ranks better than 89.44% on this metric.
During the past 12 months, Omega Healthcare Investors's average EPS without NRI Growth Rate was 18.40% per year.
During the past 3 years, the average EPS without NRI Growth Rate was 38.90% per year.
During the past 5 years, the average EPS without NRI Growth Rate was 12.10% per year.
During the past 10 years, the average EPS without NRI Growth Rate was -3.20% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.
During the past 13 years, the highest 3-Year average EPS without NRI Growth Rate of Omega Healthcare Investors was 41.70% per year. The lowest was -38.40% per year. And the median was 8.30% per year.
EPS without NRI is the amount of earnings without non-recurring items per outstanding share of the company's stock.
Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists Earnings per share without Non-Recurring Items, which better reflects the company's underlying performance.
Omega Healthcare Investors 3-Year EPS without NRI Growth Rate Related Terms
BSP:O2HI34 vs DOC, AHR, CTRE: 3-Year EPS without NRI Growth Rate Comparison
For the REIT - Healthcare Facilities subindustry, Omega Healthcare Investors's 3-Year EPS without NRI Growth Rate, along with its competitors' market caps and 3-Year EPS without NRI Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Omega Healthcare Investors 3-Year EPS without NRI Growth Rate vs REITs Industry
For the REITs industry and Real Estate sector, Omega Healthcare Investors's 3-Year EPS without NRI Growth Rate distribution charts can be found below:
* The bar in red indicates where Omega Healthcare Investors's 3-Year EPS without NRI Growth Rate falls into.
Omega Healthcare Investors 3-Year EPS without NRI Growth Rate Calculation
This is the 3-year average growth rate of EPS without NRI. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.
What does a 3-Year EPS without NRI Growth Rate of 38.90% mean?
Omega Healthcare Investors (BSP:O2HI34) has a 3-Year EPS without NRI Growth Rate of 38.90% as of Mar. 2026. 3-Year EPS without NRI Growth Rate is the 3-year average growth rate of EPS without NRI. View historical data for Omega Healthcare Investors and its competitors. This is 369% above median its historical median of 8.30. According to the industry distribution chart, Omega Healthcare Investors ranks #72 out of 682 companies in the REITs industry, placing it in the top 10.6%.
Is Omega Healthcare Investors' 3-Year EPS without NRI Growth Rate too high?
Omega Healthcare Investors' current 3-Year EPS without NRI Growth Rate of 38.90% is 369% above median its 10-year median of 8.30. The REITs industry median 3-Year EPS without NRI Growth Rate is 1.05. Omega Healthcare Investors' value of 38.90% is 3604.8% above this industry median. Based on the distribution chart, Omega Healthcare Investors ranks #72 out of 682 companies in the REITs industry, which is in the top quartile — a strong position relative to peers. Overall, Omega Healthcare Investors has a GF Score™ of 49/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Omega Healthcare Investors' 3-Year EPS without NRI Growth Rate compare to DOC and AHR?
According to the REITs industry distribution chart, Omega Healthcare Investors ranks #72 out of 682 companies for 3-Year EPS without NRI Growth Rate. This places Omega Healthcare Investors in the top 11% of its industry — outperforming the majority of peers. The industry median 3-Year EPS without NRI Growth Rate is 1.05. Omega Healthcare Investors' value of 38.90% is 3604.8% above this benchmark. While the company's 10-year median is 8.30 vs. the industry median of 1.05, Omega Healthcare Investors has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year EPS without NRI Growth Rate for a REITs company?
The median 3-Year EPS without NRI Growth Rate among REITs companies is 1.05, based on 682 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year EPS without NRI Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year EPS without NRI Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Omega Healthcare Investors's current 3-Year EPS without NRI Growth Rate of 38.90% is 3604.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year EPS without NRI Growth Rate mean?
A high 3-Year EPS without NRI Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year EPS without NRI Growth Rate is the 3-year average growth rate of EPS without NRI. View historical data for Omega Healthcare Investors and its competitors. For the REITs industry, the median 3-Year EPS without NRI Growth Rate is 1.05 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Omega Healthcare Investors's current 3-Year EPS without NRI Growth Rate is 38.90%, which is 369% above median its own 10-year median of 8.30. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Omega Healthcare Investors stock overvalued right now?
Based on GuruFocus' analysis, Omega Healthcare Investors (BSP:O2HI34) is currently considered Modestly Overvalued. The stock's GF Value™ is R$60.64, compared to a current price of R$77.02 — trading 27% above its estimated fair value. The current 3-Year EPS without NRI Growth Rate is 38.90%, which is 369% above median its 10-year median of 8.30 and 3604.8% above the REITs industry median of 1.05. Omega Healthcare Investors' overall GF Score™ is 49/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year EPS without NRI Growth Rate calculated?
3-Year EPS without NRI Growth Rate is calculated from a company's financial statements. For Omega Healthcare Investors (BSP:O2HI34), the current 3-Year EPS without NRI Growth Rate is 38.90% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Omega Healthcare Investors (BSP:O2HI34) Overvalued in 2026?
Based on GuruFocus' analysis, Omega Healthcare Investors stock appears to be overvalued.
The current stock price of R$77.02 is trading 27% above its estimated GF Value™ of R$60.64.
GuruFocus considers Omega Healthcare Investors to be Modestly Overvalued.
Key valuation signals for BSP:O2HI34:
3-Year EPS without NRI Growth Rate: 38.90% (369% above median its 10-year median of 8.30)
GF Value™: R$60.64 vs. price of R$77.02 (27% above fair value)
Industry Position: 3604.8% above the REITs median (#72 of 682)
No single metric tells the full story. See the BSP:O2HI34 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Omega Healthcare Investors Inc is a real estate investment trust that invests in healthcare-related real estate properties located in the United States (U.S.), the United Kingdom (U.K.), and Canada. The company's objective is to provide attractive returns to investors while serving as the preferred capital partner to its third-party healthcare operating companies and affiliates, as well as other third-party healthcare operators, allowing them to focus on delivering a high level of care to their resident patients. Omega's investment portfolio mainly consists of skilled nursing facilities, assisted living facilities (ALFs), including care homes in the U.K., independent living facilities, rehabilitation and acute care facilities, and continuing care retirement communities.
49GF Score
Get the complete analysis for BSP:O2HI34
3-Year EPS without NRI Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BSP:O2HI34 has been successfully added to your 